Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal honey added to standard antibiotics for cervicitis
IRCT20180707040370N3Phase 2Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Revamil, azithromycin and cefixime in cervicitis (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Pain intensity and Erosion. Started Jan 2018; status: completed.
02
Drugs
Revamilazithromycincefixime
03
Conditions
cervicitis
Beyond the preview
Go deeper on IRCT20180707040370N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180707040370N3.